Anaergia Bilan de santé

Santé financière contrôle des critères 4/6

Anaergia possède un total de capitaux propres de CA$67.8M et une dette totale de CA$57.7M, ce qui porte son ratio d'endettement à 85.1%. Son actif total et son passif total sont CA$240.3M et de CA$172.5M.

Informations clés

85.1%

Ratio d'endettement

CA$57.73m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	CA$40.24m
Fonds propres	CA$67.82m
Total du passif	CA$172.49m
Total des actifs	CA$240.31m

Mises à jour récentes de la santé financière

Does Anaergia (TSE:ANRG) Have A Healthy Balance Sheet?

Sep 18

Recent updates

Need To Know: Analysts Just Made A Substantial Cut To Their Anaergia Inc. (TSE:ANRG) Estimates

May 16

Earnings Update: Anaergia Inc. (TSE:ANRG) Just Reported And Analysts Are Trimming Their Forecasts

May 14

Analysts Just Made A Major Revision To Their Anaergia Inc. (TSE:ANRG) Revenue Forecasts

Nov 13

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de ANRG ( CA$116.5M ) dépassent ses passifs à court terme ( CA$97.0M ).

Passif à long terme: Les actifs à court terme de ANRG ( CA$116.5M ) dépassent ses passifs à long terme ( CA$75.5M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de ANRG ( 25.8% ) est considéré comme satisfaisant.

Réduire la dette: Données insuffisantes pour déterminer si le ratio d'endettement de ANRG a diminué au cours des 5 dernières années.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: ANRG dispose d'une piste de trésorerie suffisante pour plus d'un an sur la base de son flux de trésorerie disponible actuel.

Prévisions de trésorerie: ANRG dispose de moins d'un an de marge de trésorerie si le flux de trésorerie disponible continue de diminuer à un taux historique de 1.8 % chaque année

Anaergia Bilan de santé

Santé financière contrôle des critères 4/6

Informations clés

Mises à jour récentes de la santé financière

Does Anaergia (TSE:ANRG) Have A Healthy Balance Sheet?

Recent updates

Third quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.48 loss in 3Q 2023)

Anaergia Inc.'s (TSE:ANRG) 31% Jump Shows Its Popularity With Investors

Interim Chief Financial Officer recently bought CA$78k worth of stock

Does Anaergia (TSE:ANRG) Have A Healthy Balance Sheet?

Independent Director recently bought CA$61k worth of stock

Executive Director recently bought CA$109k worth of stock

Anaergia Inc. Announces Appointment of Gregory Wolf, Interim Chief Financial Officer to Permanent Chief Financial Officer

Second quarter 2024 earnings released: CA$0.04 loss per share (vs CA$1.78 loss in 2Q 2023)

Anaergia Inc. (TSE:ANRG) Soars 92% But It's A Story Of Risk Vs Reward

Less than half of directors are independent

Anaergia Inc. Announces Chairman Changes

First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.17 loss in 1Q 2023)

Less than half of directors are independent

Anaergia Inc. Announces CEO Changes

Anaergia Inc. Announces Resignation of Frank Mckenna as Board of Directors

Anaergia Inc., Annual General Meeting, Jun 24, 2024

Less than half of directors are independent

Anaergia Inc. Announces Board Changes

Price target decreased by 20% to CA$0.33

New major risk - Shareholder dilution

Anaergia Inc. announced that it expects to receive CAD 40.8 million in funding from Marny Holdco

Anaergia Inc. announced that it expects to receive CAD 40.8 million in funding from Marny Holdco

Anaergia Inc. announced that it expects to receive CAD 40.8 million in funding from Marny Holdco

New minor risk - Profitability

Forecast breakeven date pushed back to 2025

Insufficient new directors

Anaergia Inc. to Report Q3, 2023 Results on Nov 14, 2023

SMK Law P.C. and Bates Barristers Announces an Amended Statement of Claim Has Been Filed in the Proposed Class Action Lawsuit Against Anaergia Inc

SMK Law P.C. and Bates Barristers Announces an Amended Statement of Claim Has Been Filed in the Proposed Class Action Lawsuit Against Anaergia Inc

Anaergia Inc. Withdraws Earnings Guidance for the Fiscal Year 2023

Forecast breakeven date pushed back to 2025

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Anaergia Inc. to Report Q2, 2023 Results on Aug 14, 2023

Price target increased by 9.1% to CA$2.29

Price target decreased by 25% to CA$2.10

Anaergia Inc. Announces CEO Changes

Anaergia Inc. Announces Appointment of Andrew Spence as Chief Financial Officer

Need To Know: Analysts Just Made A Substantial Cut To Their Anaergia Inc. (TSE:ANRG) Estimates

Earnings Update: Anaergia Inc. (TSE:ANRG) Just Reported And Analysts Are Trimming Their Forecasts

Price target increased by 16% to CA$5.48

Anaergia Inc. Updates Earnings Guidance for the Fiscal Year of 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.3% to CA$4.73

Consensus EPS estimates have been downgraded.

Consensus EPS estimates have been downgraded.

Price target decreased by 11% to CA$7.56

Insufficient new directors

Price target decreased by 7.1% to CA$8.53

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Analysts Just Made A Major Revision To Their Anaergia Inc. (TSE:ANRG) Revenue Forecasts

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to CA$17.29

Anaergia Inc. Revises Revenue Guidance for Fiscal 2022

Anaergia Inc. to Report Q3, 2022 Results on Nov 10, 2022

Anaergia Inc. Appoints Paula Myson as Chief Financial Officer

Anaergia Inc. Reaffirms Financial Guidance for the Fiscal 2022 and Fiscal 2023

Anaergia Inc. to Report Q2, 2022 Results on Aug 15, 2022

Anaergia Inc. to Report Q2, 2022 Results on Aug 15, 2022

Anaergia Inc. Announces Executive Changes

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Consensus forecasts updated

Executive Chairman & CEO recently bought CA$5.0m worth of stock

Executive Chairman & CEO recently bought CA$5.0m worth of stock

Anaergia Inc. to Report Q1, 2022 Results on May 12, 2022

Anaergia Inc. has completed a Follow-on Equity Offering in the amount of CAD 60 million.

Anaergia Inc., Annual General Meeting, Jun 17, 2022

Full year 2021 earnings: Revenues exceed analyst expectations

Anaergia Inc. Provides Earnings Guidance for the Fiscal Year 2022 and 2023

Anaergia Inc. to Report Q4, 2021 Results on Mar 28, 2022

Anaergia Inc. has completed an IPO in the amount of CAD 175 million.

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des pistes de trésorerie